145514-62-1,
(2R,3S)-boc-3-Phenylisoserine,
(2R,3S)-N-Boc-3-Phenylisoserine,
Boc-(2R,3S)-3-phenylisoserine,
(2R,3S)-3-Boc-amino-2-hydroxy-3-phenyl-propanoic acid,
(2R,3S)-3-((tert-Butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoic acid,
AK-44533,
SCHEMBL144832,
Jsp002664,
CTK4C4582,
DTXSID80426688,
Benzenepropanoic acid, b-[[(1,1-dimethylethoxy)carbonyl]amino]-a-hydroxy-, (aR,bS)-,
BCP13720,
ZINC2392276,
(2R,3S)-3-tert-Butoxycarbonylamino-2-hydroxy-3-phenyl-propionic acid,
ANW-44745,
MFCD02259481,
(2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenyl-propanoic acid,
AKOS015890748,
AC-6412,
CB-2187,
AJ-35824,
AN-10025,
DS-13365,
Q743,
AX8031959,
DB-002314,
RT-011581,
ST2414221,
FT-0772733,
K-4658,
514B621,
I01-7941,
(2R,3S)-3-tert-Butoxycarbonylamino-2-hydroxy-3-phenylpropionic acid,
Docetaxel Related Compound 2 ((2R, 3S)-Boc-3-Phenylisoserine),
Benzenepropanoic acid, beta-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-hydroxy-, (alphaR,betaS)-,
C14H19NO5,
ACN-032473,
CID7010687,
(2R,3S)-N-t-Butoxycarbonyl-3-phenylisoserine,
(2R,3R)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenyl-propanoic Acid,
126252-53-7,